CVR: 43517252
DKK 75,860
Gross profit
Net result: DKK -678,796
Faaborg Løve Produkter Holding I ApS
CVR · view ownership and management
Owner registered: Faaborg Løve Produkter Holding I ApS
CVR · 15/12/2022
View the full event history
Faaborg Pharma - IP ApS is a Danish company of the type Anpartsselskab based in Faaborg, founded in 2022. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The management consists of Jan Knudsen. The company is owned by Faaborg Løve Produkter Holding I ApS. In 2025, the company reported a gross profit of DKK 75,860 and a net result of DKK -678,796 compared with DKK -895,356 the year before. Equity in the 2025 report amounted to DKK -2,291,658.
Selskabets formål er handel samt anden hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
Compared to 221 companies in Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreFaaborg Pharma - IP ApS was founded on 12 September 2022.
Faaborg Pharma - IP ApS is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker (industry code 774000).
Faaborg Pharma - IP ApS is owned by Faaborg Løve Produkter Holding I ApS.
In 2025, Faaborg Pharma - IP ApS reported a gross profit of DKK 75,860.
The management of Faaborg Pharma - IP ApS consists of Jan Knudsen.
Faaborg Pharma - IP ApS is located at Markedspladsen 13A, 5600 Faaborg.
Claim this page to add your logo and social links. Free to get started.
Faaborg Pharma - IP ApS has published its annual report for 2025. Gross profit came to DKK 75,860, and the net result was DKK -678,796.
Faaborg Pharma - IP ApS has published its annual report for 2024. Gross profit came to DKK -247,665, and the net result was DKK -895,356.
Faaborg Pharma - IP ApS has published its interim report for the period September 12, 2022 – December 31, 2023.
As of August 21, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Faaborg Pharma - IP ApS.
As of August 21, 2023, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Faaborg Pharma - IP ApS.
As of December 15, 2022, Faaborg Løve Produkter Holding I ApS is registered as an owner of Faaborg Pharma - IP ApS with an ownership share of 100%.
As of September 12, 2022, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Faaborg Pharma - IP ApS.
As of September 12, 2022, Jan Knudsen has joined the board of directors of Faaborg Pharma - IP ApS.
As of September 12, 2022, Birk Simon Maldonado Andersen has joined the board of directors of Faaborg Pharma - IP ApS.
As of September 12, 2022, Claus Wædeled has joined the board of directors of Faaborg Pharma - IP ApS.
As of September 12, 2022, Jan Knudsen is registered as director of Faaborg Pharma - IP ApS.
Faaborg Pharma - IP ApS was founded on September 12, 2022.
Companies in the same industry and area
CVR 25293584
CVR 32317782
CVR 41185503
